← All trials
NCT00334386
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2005
- Primary completion
- —
- Completion date
- Feb 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 388
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Ferrer Internacional S.A.Lead sponsor
- Centre d'Atenció Primaria Bon PastorOverall official - principal investigator
- Centro de Salud La Roda, La Roda, Albacete, SpainOverall official - principal investigator
- Centro de Salud de Fuentealbilla, Fuentealbilla, Albacete, SpainOverall official - principal investigator
- Centro de Salud de Chinchilla, Chinchilla, Albacete, SpainOverall official - principal investigator
- Centre de Salut de Guisona, Guisona, Lleida, SpainOverall official - principal investigator
- University of BarcelonaOverall official - principal investigator
- University AlicanteOverall official - principal investigator
- Hospital Municipal de BadalonaOverall official - principal investigator
- St. Petersburg City Hospital #31, St. Petesburg, RussiaOverall official - principal investigator
- St. Petersburg City Hospital #15, St. Petesburg, RussiaOverall official - principal investigator
- Krasnogvardeysky District Medical-Physiology Clinic, St. Petesburg, RussiaOverall official - principal investigator
- St. Petersburg City Outpatient Unit #109, St. Petersburg, RussiaOverall official - principal investigator
- St. Petersburg City Outpatient Unit #25, St. Petesburg, RussiaOverall official - principal investigator
- St. Petersburg Mechnikov State Medical AcademyOverall official - principal investigator
- St. Petersburg Mechnikov State Medical Academy, RussiaOverall official - principal investigator
- Moscow City Hospital #61Overall official - principal investigator
- Pokrovskaya Hospital, St. Petesburg, RussiaOverall official - principal investigator
- St. Elizabeth City Hospital, St. Petersburg, RussiaOverall official - principal investigator
- St. Petersburg City Hospital #8, St. Petesburg, RussiaOverall official - principal investigator
- University of BarcelonaStudy chair
- Universitario de Santiago, SpainOverall official - principal investigator
- Moscow City Hospital #23Overall official - principal investigator
- Hospital de MataróOverall official - principal investigator
- JSC Scientific Center for Anti-infectious DrugsOverall official - principal investigator
- Smolensk State Medical AcademyOverall official - principal investigator
- Universidad Autonoma de MadridOverall official - principal investigator
- Hospital Universitario Central de AsturiasOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.